Quest Diagnostics CEO Disposes of $1.25M in Stock for Tax Purposes
QUEST DIAGNOSTICS INC
Subscribe to track DGX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Quest Diagnostics CEO Disposes of $1.25M in Stock for Tax Purposes
Company: QUEST DIAGNOSTICS INC (DGX) Form: 4 | Filed: 2025-11-07 Significance: Low
Insider: Davis J. E. Title: CEO and President | Relationship: Director, Officer
Transaction: • Type: Tax Withholding Sale • Shares: 7,143 • Price: $175.57 • Value: $1,253,914 • Owned After: 120,480
Key Insight: This was a non-discretionary sale (Code 'F') to cover tax obligations from vested RSUs, not an open-market sale reflecting insider sentiment.
Market Context: The transaction value represents a negligible 0.006% of the company's $19.64B market capitalization.
Comprehensive Analysis
SEC Filing Analysis: QUEST DIAGNOSTICS INC (DGX)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The CEO disposed of shares in a non-discretionary transaction to cover tax liabilities from vested restricted stock units (RSUs). This is not an indicator of insider sentiment.
- Market Impact: Neutral. This type of transaction is routine and does not signal a change in the insider's view of the company's future prospects.
Company Information
| Field | Value |
|---|---|
| Company | QUEST DIAGNOSTICS INC |
| Ticker Symbol | DGX |
| CIK | 0001022079 |
| Industry | Medical Laboratories |
Insider Information
| Field | Value |
|---|---|
| Name | Davis J. E. |
| CIK | 0001599837 |
| Title/Position | CEO and President |
| Relationship | Director, Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-05 |
| Transaction Code | F - Payment of tax liability by withholding securities |
| Security Type | Common Stock |
| Shares Involved | 7,143 |
| Price Per Share | $175.57 |
| Total Value | $1,253,913.51 |
| Shares Owned After | 120,480 |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $1,253,913.51 |
| % of Market Cap | 0.006% |
| Shares Transacted | 7,143 |
| % of Shares Outstanding | 0.006% |
| Post-Transaction Ownership | 120,480 shares (0.108% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The $1.25 million transaction is immaterial relative to Quest Diagnostics' $19.64 billion market capitalization.
- Ownership Concentration: The CEO's ownership remains at approximately 0.108% of total shares outstanding, indicating his holdings are still aligned with shareholder interests.
- Transaction Significance: The transaction is insignificant, representing less than 0.01% of both market cap and shares outstanding. Its purpose, as a tax-related disposition, further reduces its market signaling value to zero.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction was a pre-disclosed, non-discretionary disposition to cover tax obligations. It does not reflect a voluntary decision to sell based on market conditions or company performance.
Volume & Sentiment
- Expected Volume Impact: Negligible. The shares were withheld by the issuer and not sold on the open market, so there is no direct impact on trading volume.
- Sentiment Indicator: Neutral. This filing provides no bullish or bearish signals.
Additional Context
Transaction Notes
- Special Circumstances: The filing's footnote explicitly states, "Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units." This confirms the non-discretionary nature of the event.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
